853 related articles for article (PubMed ID: 19025914)
1. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
[TBL] [Abstract][Full Text] [Related]
3. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
[TBL] [Abstract][Full Text] [Related]
4. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
6. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
[TBL] [Abstract][Full Text] [Related]
10. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
11. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
Thuluvath PJ; Yoo HY
Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
[TBL] [Abstract][Full Text] [Related]
13. Is recurrent hepatitis C worse with living donors?
Kuo A; Terrault NA
Curr Opin Organ Transplant; 2009 Jun; 14(3):240-4. PubMed ID: 19395968
[TBL] [Abstract][Full Text] [Related]
14. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
15. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
Lawal A; Ghobrial R; Te H; Artinian L; Eastwood D; Schiano TD
Transplant Proc; 2007 Dec; 39(10):3261-5. PubMed ID: 18089367
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.
Garcia-Retortillo M; Forns X; Llovet JM; Navasa M; Feliu A; Massaguer A; Bruguera M; Fuster J; Garcia-Valdecasas JC; Rimola A
Hepatology; 2004 Sep; 40(3):699-707. PubMed ID: 15349910
[TBL] [Abstract][Full Text] [Related]
18. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
19. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.
Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M
Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676
[TBL] [Abstract][Full Text] [Related]
20. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]